Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$429K Buy
1,537
+158
+11% +$44.8K 0.15% 84
2025
Q1
$430K Sell
1,379
-102
-7% -$30.1K 0.16% 78
2024
Q4
$386K Buy
1,481
+24
+2% +$7.12K 0.15% 77
2024
Q3
$469K Buy
1,457
+5
+0.3% +$1.64K 0.18% 65
2024
Q2
$454K Hold
1,452
0.2% 54
2024
Q1
$413K Sell
1,452
-2
-0.1% -$585 0.19% 54
2023
Q4
$419K Buy
1,454
+128
+10% +$34.9K 0.21% 51
2023
Q3
$356K Buy
1,326
+2
+0.2% +$499 0.19% 60
2023
Q2
$294K Buy
1,324
+71
+6% +$16.5K 0.12% 84
2023
Q1
$303K Buy
1,253
+1,200
+2,264% +$295K 0.16% 71
2022
Q4
$13.9K Buy
53
+24
+83% +$6.43K 0.01% 329
2022
Q3
$7K Sell
29
-1
-3% -$242 ﹤0.01% 374
2022
Q2
$7K Buy
30
+22
+275% +$5.39K ﹤0.01% 368
2022
Q1
$2K Hold
8
﹤0.01% 438
2021
Q4
$2K Buy
+8
New +$1.69K ﹤0.01% 442
2021
Q2
$2K Hold
8
﹤0.01% 399
2021
Q1
$2K Sell
8
-34
-81% -$8.11K ﹤0.01% 363
2020
Q4
$10K Buy
42
+23
+121% +$5.3K 0.01% 257
2020
Q3
$5K Sell
19
-18
-49% -$4.46K 0.01% 252
2020
Q2
$9K Buy
+37
New +$8.44K 0.01% 183

Other funds holding AMGN

Horan Securities's AMGN Position: Q2 2025 in Review

Horan Securities increased its Amgen (AMGN) stake by 11% in Q2 2025, buying an estimated $44.8K and bringing the position to 1,537 shares worth $429K. The position accounts for 0.15% of the portfolio, ranked #84.

Horan Securities first reported a position in AMGN in Q2 2020 and has held it in 20 quarters since. The position peaked at $469K in Q3 2024. 2,856 funds tracked by Wall St. Rank hold AMGN as of Q2 2025.

  • Horan Securities held 1,537 shares of Amgen worth $429K as of Q2 2025.
  • Horan Securities bought 158 Amgen shares in Q2 2025, an estimated $44.8K.
  • Amgen made up 0.15% of Horan Securities's portfolio in Q2 2025, its #84 holding.
  • Horan Securities first reported a position in Amgen in Q2 2020 and has held it in 20 quarters since.
  • Horan Securities's Amgen position peaked at $469K in Q3 2024.
  • 2,856 funds tracked by Wall St. Rank held Amgen as of Q2 2025.

Based on Horan Securities's 13F filing for Q2 2025, filed 6 Aug 2025.